Therapeutic aspects of myelodysplastic syndromes in chronic phase
- 1 January 1992
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 16 (1) , 95-100
- https://doi.org/10.1016/0145-2126(92)90107-i
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Treatment of myelodysplastic syndrome and atypical leukemia with low-dose aclarubicinLeukemia Research, 1990
- Myelodysplastic Syndrome: Prospective Evaluation of Fifty-One Patients Using the Dutcher Scoring SystemActa Haematologica, 1989
- Successful oral chemotherapy with idarubicin in refractory anaemia with excess blastsEuropean Journal of Haematology, 1987
- Treatment of preleukemic syndromes with marrow transplantationBlood, 1987
- High-dose cytosine arabinoside in the treatment of preleukemic disorders: A leukemia intergroup studyAmerican Journal of Hematology, 1986
- The role of aggressive chemotherapy in the treatment of the myelodysplastic syndromesBritish Journal of Haematology, 1986
- Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysisBritish Journal of Haematology, 1985
- Myelodysplastic syndromes: a scoring system with prognostic significanceBritish Journal of Haematology, 1985
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982
- DIFFERENTIATION OF MYELOID LEUKAEMIC CELLS: NEW POSSIBILITIES FOR THERAPYBritish Journal of Haematology, 1979